Comprehensive Analysis of PD-L1 Expression in Glioblastoma Multiforme

Oncotarget - United States
doi 10.18632/oncotarget.15031
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

Crosslink Between Temozolomide and PD-L1 Immune-Checkpoint Inhibition in Glioblastoma Multiforme

BMC Cancer
Cancer ResearchOncologyGenetics
2019English

Growth and Differentiation Factor 15 Regulates PD-L1 Expression in Glioblastoma

Cancer Management and Research
Oncology
2019English

PD-L1 Expression and Combined Status of PD-L1/PD-1–Positive Tumor Infiltrating Mononuclear Cell Density Predict Prognosis in Glioblastoma Patients

Journal of Pathology and Translational Medicine
Forensic MedicinePathologyHistology
2017English

Comprehensive Portrait of Recurrent Glioblastoma Multiforme in Molecular and Clinical Characteristics

Oncotarget
Oncology
2015English

A Radiosensitivity Gene Signature and PD-L1 Status Predict Clinical Outcome of Patients With Glioblastoma Multiforme in the Cancer Genome Atlas Dataset

Cancer Research and Treatment
Cancer ResearchOncology
2020English

PD-L1 Expression in Inflammatory Myofibroblastic Tumors

Modern Pathology
Forensic MedicinePathology
2018English

PD-L1 Expression in Triple-Negative Breast Cancer

Cancer immunology research
Cancer ResearchImmunology
2014English

The Expression of PD-L1 in Salivary Gland Carcinomas

Scientific Reports
Multidisciplinary
2019English

Glioblastoma Multiforme Cerebelar

JBNC - JORNAL BRASILEIRO DE NEUROCIRURGIA
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy